Evidence map›Paper›PMID 37634571›Full record

ArticleThe ocular surface2023

TNF is a critical cytokine in age-related dry eye disease.

Yashaswini Kelagere, Kaitlin K Scholand, Erica N DeJong, Andrea I Boyd, Zhiyuan Yu, Roger A Astley, Michelle C Callegan, Dawn Me Bowdish, Helen P Makarenkova, Cintia S de Paiva

Open access · greenAbstract read
In one paragraph

Article in The ocular surface, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Yashaswini KelagereOcular Surface Center, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA. Electronic address: yashaswinikelagere@gmail.com.
Kaitlin K ScholandOcular Surface Center, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA; Biochemistry and Cell Biology Graduate Program, Department of BioSciences, Rice University, Houston, TX, USA. Electronic address: Kaitlin.Scholand@bcm.edu.
Erica N DeJongMcMaster Immunology Research Centre, McMaster University, Ontario, Canada. Electronic address: dejone1@mcmaster.ca.
Andrea I BoydGraduate Program in Immunology & Microbiology, Baylor College of Medicine, USA. Electronic address: Andrea.Lee@bcm.edu.
Zhiyuan YuOcular Surface Center, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA. Electronic address: zhiyuanyu@hotmail.com.
Roger A AstleyDepartments of Ophthalmology and Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: Roger-Astley@ouhsc.edu.
Michelle C CalleganDepartments of Ophthalmology and Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: Michelle-Callegan@ouhsc.edu.
Dawn Me BowdishMcMaster Immunology Research Centre, McMaster University, Ontario, Canada. Electronic address: bowdish@mcmaster.ca.
Helen P MakarenkovaDepartment of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA. Electronic address: hmakarenk@scripps.edu.
Cintia S de PaivaOcular Surface Center, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA; Biochemistry and Cell Biology Graduate Program, Department of BioSciences, Rice University, Houston, TX, USA. Electronic address: cintiadp@bcm.edu.
Baylor College of Medicine · USMcMaster University Medical Centre · CAUniversity of Oklahoma Health Sciences Center · USScripps Research Institute · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
Lacrimal Gland Repair Using Progenitor CellsR01EY026202 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI MAKARENKOVA, HELEN P. · 2016 to 2025
$5.2M
VISUAL SCIENCEST32EY007001 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$3.7M
Defining the interplay of interferon-gamma and cathepsin S in age-related dry eyeR01EY030447 · NEI · BAYLOR COLLEGE OF MEDICINE · PI DE PAIVA, CINTIA S. · 2020 to 2023
$1.6M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
NCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NEI NIH HHS P30 EY002520NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY026202NEI NIH HHS R01 EY030447NEI NIH HHS T32 EY007001
6 · The paper itself

Abstract

Aging is a complex biological process that is characterized by low-grade inflammation, called inflammaging. Aging affects multiple organs including eye and lacrimal gland. Tumor necrosis factor (TNF) is a pleiotropic cytokine that participates in inflammation, activation of proteases such as cathepsin S, and formation of ectopic lymphoid organs. Using genetic and pharmacological approaches, we investigated the role of TNF in age-related dry eye disease, emphasizing the ocular surface and lacrimal gland inflammation. Our results show the increased protein and mRNA levels of TNF in aged lacrimal glands, accompanied by increased TNF, IL1β, IL-18, CCL5, CXCL1, IL-2, IL-2 receptor alpha (CD25), IFN-γ, IL-12p40, IL-17, and IL-10 proteins in tears of aged mice. Moreover, genetic loss of the Tnf

Indexed as

Dry Eye SyndromesLacrimal ApparatusAnimalsCytokinesDisease Models, AnimalInflammationMiceTearsTumor Necrosis Factor-alphaCytokinesTumor Necrosis Factor-alphaAgingDry eyeGoblet cell densityLacrimal glandTearsTumor necrosis factor

Identifiers

PMID37634571
PMCPMC10812879
OpenAlexW4386154552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.